scholarly journals Pegylated Interferon‐α for Treating Chronic Hepatitis E Virus Infection after Liver Transplantation

2010 ◽  
Vol 50 (5) ◽  
pp. e30-e33 ◽  
Author(s):  
Nassim Kamar ◽  
Lionel Rostaing ◽  
Florence Abravanel ◽  
Cyril Garrouste ◽  
Laure Esposito ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Chronic Hepatitis ◽  
Virus Infection ◽  
Hepatitis E Virus ◽  
Pegylated Interferon ◽  
Hepatitis E ◽  
Interferon Α

scholarly journals Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient

2010 ◽  
Vol 25 (8) ◽  
pp. 2792-2795 ◽  
Author(s):  
N. Kamar ◽  
F. Abravanel ◽  
C. Garrouste ◽  
I. Cardeau-Desangles ◽  
J. M. Mansuy ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Virus Infection ◽  
Interferon Alpha ◽  
Hepatitis E Virus ◽  
Haemodialysis Patient ◽  
Pegylated Interferon ◽  
Hepatitis E ◽  
Pegylated Interferon Alpha

scholarly journals Chronic hepatitis E virus infection beyond transplantation or human immunodeficiency virus infection

Hepatology ◽  
2014 ◽  
Vol 60 (3) ◽  
pp. 1112-1113 ◽  
Author(s):  
Christoph Höner zu Siederdissen ◽  
Sven Pischke ◽  
Jerome Schlue ◽  
Katja Deterding ◽  
Timo Hellms ◽  
...  
Keyword(s):  
Human Immunodeficiency Virus ◽  
Chronic Hepatitis ◽  
Virus Infection ◽  
Human Immunodeficiency Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Immunodeficiency Virus

scholarly journals Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients

2019 ◽  
Vol 6 (9) ◽  
Author(s):  
Caroline Protin ◽  
Florence Abravanel ◽  
Laurent Alric ◽  
Suzanne Tavitian ◽  
Lucie Obéric ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Virus Infection ◽  
B Cell ◽  
Viral Hepatitis ◽  
Hepatitis E Virus ◽  
Kinase Inhibitor ◽  
Hepatitis E ◽  
Single Center ◽  
Lymphoid Malignancies ◽  
Single Center Experience

Abstract Ibrutinib is an oral first-in-class Bruton’s tyrosine kinase inhibitor approved for the therapy of various B-cell lymphoid malignancies. Among ibrutinib-related infections, viral hepatitis are poorly described. We report our single-center experience with 4 cases of chronic hepatitis E virus infection and their management with ribavirin.

scholarly journals A Nationwide Survey of Hepatitis E Virus Infection and Chronic Hepatitis in Heart and Kidney Transplant Recipients in Japan

2020 ◽  
Vol 104 (2) ◽  
pp. 437-444 ◽  
Author(s):  
Yohei Owada ◽  
Yukio Oshiro ◽  
Yuki Inagaki ◽  
Hiroshi Harada ◽  
Nobuhiro Fujiyama ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Virus Infection ◽  
Kidney Transplant ◽  
Hepatitis E Virus ◽  
Nationwide Survey ◽  
Hepatitis E ◽  
Transplant Recipients ◽  
Kidney Transplant Recipients

Therapeutic window for ribavirin therapy in transplant recipients with chronic hepatitis E virus infection

2020 ◽  
Vol 73 ◽  
pp. S855-S856
Author(s):  
Midas Mulder ◽  
Robert De Man ◽  
Nassim Kamar ◽  
Gülcan Durmaz ◽  
Joep de Bruijne ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Virus Infection ◽  
Hepatitis E Virus ◽  
Hepatitis E ◽  
Therapeutic Window ◽  
Transplant Recipients

scholarly journals Mystery of Hepatitis E Virus: Recent Advances in Its Diagnosis and Management

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Aftab Ahmed ◽  
Ijlal Akbar Ali ◽  
Hira Ghazal ◽  
Javid Fazili ◽  
Salman Nusrat
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis E Virus ◽  
Treatment Options ◽  
Antiviral Drug ◽  
Pegylated Interferon ◽  
Hepatitis E ◽  
Recent Advances ◽  
Immunosuppressed Patients ◽  
History Of ◽  
Acute And Chronic Hepatitis

Mysterious aspects of the long presumed to be well-known hepatitis E virus (HEV) have recently surfaced that distinguish it from other hepatotropic viruses. It is a cause of chronic hepatitis in immunosuppressed patients. It has human to human transmission through blood and mantains high seroprevalence in blood donors. HEV has also been found to occur more frequently in the West in those without a history of travel to endemic countries. It has varied extrahepatic manifestations and has multiple non-human reservoirs including pigs and rats. Considering these recent discoveries, it appears odd that HEV is not sought more frequently when working up acute and chronic hepatitis patients. The disease is particularly severe among pregnant women and has a high attack rate in young adults. What adds to its ambiguity is the absence of a well-established diagnostic criteria for its detection and that there is no specific antiviral drug for hepatitis E, except for isolated cases where ribavirin or pegylated interferon alpha has been used with occasional success. This review paper discusses the recent advances in the knowledge of the virus itself, its epidemiology, diagnostic approach and prevention, and the treatment options available.

scholarly journals Previous hepatitis E virus infection, cirrhosis and insulin resistance in patients with chronic hepatitis C

2019 ◽  
Vol 23 (1) ◽  
pp. 45-52 ◽  
Author(s):  
Guilherme Bricks ◽  
Jorge Figueiredo Senise ◽  
Henrique Pott-Jr ◽  
Giuliano Grandi ◽  
Dimas Carnaúba-Jr ◽  
...  
Keyword(s):  
Insulin Resistance ◽  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Virus Infection ◽  
Chronic Hepatitis C ◽  
Hepatitis E Virus ◽  
Hepatitis E
Sign in / Sign up

Export Citation Format

Share Document